Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. - Wikidata - awgldk - TriplyDB

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

http://www.wikidata.org/entity/Q38435943

about

Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillation Collateral findings during computed tomography scan for atrial fibrillation ablation: Let's take a look around Ablating Atrial Fibrillation: Customizing Lesion Sets Guided by Rotor Mapping The role of rotors in atrial fibrillation Novel Radiofrequency Ablation Strategies for Terminating Atrial Fibrillation in the Left Atrium: A Simulation Study.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Electrophysiological Perspectives on Hybrid Ablation of Atrial Fibrillation.Atrial Fibrillation and Risk of Dementia/Cognitive Decline Who Needs Catheter Ablation And Which Approach?Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?Executive Summary of the II Brazilian Guidelines for Atrial Fibrillation.Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor M Rosuvastatin reduces the recurrence rate following catheter ablation for atrial fibrillation in patients with heart failure.Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score Organized Sources Are Spatially Conserved in Recurrent Compared to Pre-Ablation Atrial Fibrillation: Further Evidence for Non-Random Electrical Substrates Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry.Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial.Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.Robotic ablation of atrial fibrillation.Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation: The Prospective, Randomized, Controlled, Noninferiority FreezeAF Study.Differences in Quality of Life Between Atrial Fibrillation Patients with Low Stroke Risk Treated With and Without Catheter Ablation.Radiofrequency Catheter Ablation Improves the Quality of Life Measured with a Short Form-36 Questionnaire in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis.Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.Left atrial appendage morphology and risk of stroke following pulmonary vein isolation for drug-refractory atrial fibrillation in low CHA2DS2Vasc risk patients.Mechanisms Underlying AF: Triggers, Rotors, Other?CoolLoop® First: A First In Man Study To Test A Novel Circular Cryoablation System In Paroxysmal Atrial Fibrillation.Indications For AF Ablation: Before Or After The Failure Of Antiarrhythmic Drug Therapy?Repeat ablation and hospitalization following cryoballoon ablation of atrial fibrillation at a single tertiary medical center.Loop Recorder Detected High Rate of Atrial Fibrillation Recurrence after a Single Balloon- or Basket-Based Ablation of Paroxysmal Atrial Fibrillation: Results of the MACPAF Study.What tissue does circumferential PV Isolation actually modulate?Atrial fibrillation and heart failure: cause or effect?Antiarrhythmic therapy in 2014: Contemporary approaches to treating arrhythmias.The year in cardiology 2014: arrhythmias and device therapy.Inflammation and the pathogenesis of atrial fibrillation.Management of atrial fibrillation: What is new in the 2014 ACC/AHA/HRS guideline?What can rhythm control therapy contribute to prognosis in atrial fibrillation?Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.Role of Rotors in the Ablative Therapy of Persistent Atrial Fibrillation.Clinical Relevance of Left Atrial Strain to Predict Recurrence of Atrial Fibrillation after Catheter Ablation: A Meta-Analysis.

P2860

Q24186195-3CCD213C-DE09-4266-9FC8-D1080ED8AA60 Q26751932-40085CBB-13C6-4BAB-97FD-29991DC765E1 Q26797445-9832851A-A185-4111-A72D-F777A49CEF94 Q27002365-D396FFC9-5A27-487F-BFB9-3A511A421A2E Q27307882-404E30C2-7E44-4E83-B0A3-61C824D21BCE Q27341873-DA98D667-D1A0-4AC6-BC34-C066B89356C3 Q28073160-33AB2229-C2EC-489A-B8D4-68DEBA8482C6 Q28074311-4AE3A8E3-6493-4503-AFA2-2800C1FE0073 Q28074710-73882009-DA8A-4354-9A87-0600E65376A9 Q28085297-BFAC00AD-1BDD-46F2-9A10-FD9385345F9D Q30101004-2195AA99-68A7-41C1-BED5-A30702033876 Q31059405-B6665760-CA1E-492E-AE7D-258B6546E6B6 Q33560704-75636B1B-52B4-4589-A7CE-65C8871D903F Q33597725-A2D0572D-01B0-4B16-9255-739FB0412700 Q33685880-D506C26C-DF73-43FA-A560-DDBCD777A528 Q33915149-AE4D645A-2AB1-44BA-BF7D-A96C0CEDC475 Q34803911-C50C2A14-EA4C-4C88-8FED-69E39C107EA7 Q35036404-B4EB5D64-4A22-4923-8329-3320EF042A07 Q35070600-FE48EF53-757A-41B6-9EE0-E71EBE1158E1 Q35975821-84D113B4-1A01-418F-BA7F-1768E164D56A Q36111390-1771536F-D3B6-4C79-B405-4B4B5C2F8ABB Q36141824-FBCC9C7C-EF1D-47A0-A612-2923DC462688 Q36147009-DD24A98C-194A-4055-97E5-C6CD194B8693 Q36162187-F6CB3D19-9A22-4B5D-89A6-6F63ACAA7C42 Q36293123-8FC23900-910F-446F-BEEC-02853CA57E3C Q36709755-A9B647B0-D4E8-4BFA-BA17-1268A871B345 Q37114587-E5A8ABC3-635A-4C2D-9F6D-BC3D18C05A6B Q37115538-1E7244D5-B968-471C-9D81-A577CDA75AC4 Q37591720-D0078EA5-55F1-4B92-9438-580C95693B63 Q37637902-38902F02-150D-400F-AC41-D3D3E0DF8437 Q37719876-B2C661EB-1653-447F-BDFA-E0CAF08BA410 Q38254552-7280FD16-C412-4865-A4D1-FD14CBD2EAF5 Q38297786-BB3E5161-FA04-46AC-98E7-9B694B65B32F Q38307425-3D53CD49-3F78-478A-8F23-021C722F95B6 Q38333088-64482E91-3E20-4C1B-85C8-CC547D771A1D Q38369003-EEB0AE08-8DDE-438B-B330-A48A31C6797E Q38384893-10F93C81-F043-4331-8C57-6E70169936E3 Q38510915-F229B020-4CA5-4A98-B46B-D83171645DE0 Q38719304-55159DC5-21B0-4354-BE98-FC88AF94096C Q38726657-A2566024-FE46-4ED2-B101-95AD2D094F72

P2860

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

http://www.wikidata.org/entity/Q38435943

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Radiofrequency ablation vs ant ...... (RAAFT-2): a randomized trial.

@en

type

label

Radiofrequency ablation vs ant ...... (RAAFT-2): a randomized trial.

@en

prefLabel

Radiofrequency ablation vs ant ...... (RAAFT-2): a randomized trial.

@en

P1433

Q38435943-48E9B5D3-C1F9-413C-A632-15C428627F1F

P1476

Q38435943-23F6EF40-CC70-4019-BAB3-021D2B943438

P2093

Q38435943-04F696ED-07AD-456D-9BD0-47E83E2B8DA6

Q38435943-1DE396B9-333D-4BE5-97E0-CA1ED4250B8E

Q38435943-3126D2FC-5EAB-4287-AF2E-78B4A173878D

Q38435943-8A005BF7-D377-40AA-9FF6-ECEB5AE024F5

Q38435943-A23E5B1F-56BF-47F7-BA09-D6882C37820F

Q38435943-A7E77D2C-B6A1-4D87-8EAD-4483E1C7B6DA

Q38435943-BFC1C32C-F403-4C09-A238-6572F9710DE4

Q38435943-C0854F95-5C79-4D4D-8A1D-89A638892E79

Q38435943-C153F56D-28DA-49C8-8A86-9AFE46739906

Q38435943-FD928FA3-E4E4-49C3-9553-EE55F1AF50B7

P304

Q38435943-2F4C2930-397E-493A-9EFD-8EE054470EA2

P31

Q38435943-7E696C80-805C-4126-B90B-8AAE0B2E6A27

P356

Q38435943-AF75A103-65FE-4EA6-A182-2455239858DB

P407

Q38435943-127A96F3-72F8-4371-83CD-852FEE7423FF

P433

Q38435943-8BD3CA2F-8C48-41B4-8592-DD24D00B6E4A

P478

Q38435943-DED95A11-DC43-405B-A71E-53EA30908B4F

P50

Q38435943-B63E4BDB-BB35-4C6E-9B51-EE59E9A5359C

P577

Q38435943-B856C03C-0276-445D-8594-88F7F6CBE8F9

P698

Q38435943-9D4DEE9A-E67E-449A-8219-0FD5BC510A6E

P921

Q38435943-3CB56579-F385-4292-995C-9FDF00A19065

P356

P1433

Journal of the American Medical Association

P1476

Radiofrequency ablation vs ant ...... (RAAFT-2): a randomized trial.

@en

P2093

Andrea Natale

http://www.w3.org/2001/XMLSchema#string

Atul Verma

http://www.w3.org/2001/XMLSchema#string

Girish M Nair

http://www.w3.org/2001/XMLSchema#string

Heather Beresh

http://www.w3.org/2001/XMLSchema#string

Jean Champagne

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Healey

http://www.w3.org/2001/XMLSchema#string

Karl H Kuck

http://www.w3.org/2001/XMLSchema#string

Laurence D Sterns

http://www.w3.org/2001/XMLSchema#string

RAAFT-2 Investigators

http://www.w3.org/2001/XMLSchema#string

Stuart J Connolly

http://www.w3.org/2001/XMLSchema#string

P304

692-700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMA.2014.467

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P50

Carlos A Morillo

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24549549

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation